Volume 15, Number 2—February 2009
Research
Methicillin-Susceptible Staphylococcus aureus in Skin and Soft Tissue Infections, Northern Italy
Table 2
Persons sampled (no.) | MSSA carriers, no. (%) | MSSA isolates |
PVL-positive isolates |
||||
---|---|---|---|---|---|---|---|
No. examined | No. PVL+ | PFGE type (no. isolates) | spa type | ST | |||
July | |||||||
Neonates (48) | 19 (39.6) | 17 | 17 | A (16) | t005 | 22 | |
B (1) | t021 | 956 | |||||
Mothers (55) | 16 (27.6) | 10 | 1 | A (1) | t005 | 22 | |
Staff (71) | 19 (26.8) | 17 | 4 | A (3) | t005 | 22 | |
A (1) |
t2336 |
954 |
|||||
December | |||||||
Neonates (43) | 0 | 0 | 0 | ||||
Mothers (17) | 5 (29.4) | 3 | 1 | A (1) | t005 | 22 | |
Staff (64) | 3 (4.7) | 3 | 2 | D (1) | t645 | 1210 | |
E (1) | t1445 | 1209 |
*PVL, Panton-Valentine leukocidin; MSSA, methicillin-susceptible Staphylococcus aureus; PFGE, pulsed-field gel electrophoresis; ST, sequence type.
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.